Epigenetic age acceleration in follicular fluid and markers of ovarian response among women undergoing IVF

被引:0
|
作者
Hood, Robert B. [1 ]
Everson, Todd M. [2 ]
Ford, Jennifer B. [3 ]
Hauser, Russ [3 ]
Knight, Anna [4 ]
Smith, Alicia K. [4 ]
Gaskins, Audrey J. [1 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd,CNR 4051, Atlanta, GA 30324 USA
[2] Emory Univ, Rollins Sch Publ Hlth, Gangarosa Dept Environm Hlth, Atlanta, CA USA
[3] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA
[4] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA
关键词
follicular fluid; Horvath age acceleration; GrimAge age acceleration; granulosa cell age acceleration; ovarian response; CELLS;
D O I
10.1093/humrep/deae136
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
STUDY QUESTION Are markers of epigenetic age acceleration in follicular fluid associated with outcomes of ovarian stimulation?SUMMARY ANSWER Increased epigenetic age acceleration of follicular fluid using the Horvath clock, but not other epigenetic clocks (GrimAge and Granulosa Cell), was associated with lower peak estradiol levels and decreased number of total and mature oocytes.WHAT IS KNOWN ALREADY In granulosa cells, there are inconsistent findings between epigenetic age acceleration and ovarian response outcomes.STUDY DESIGN, SIZE, DURATION Our study included 61 women undergoing IVF at an academic fertility clinic in the New England area who were part of the Environment and Reproductive Health Study (2006-2016).PARTICIPANTS/MATERIALS, SETTING, METHODS Participants provided a follicular fluid sample during oocyte retrieval. DNA methylation of follicular fluid was assessed using a genome-wide methylation screening tool. Three established epigenetic clocks (Horvath, GrimAge, and Granulosa Cell) were used to predict DNA-methylation-based epigenetic age. To calculate the age acceleration, we regressed epigenetic age on chronological age and extracted the residuals. The association between epigenetic age acceleration and ovarian response outcomes (peak estradiol levels, follicle stimulation hormone, number of total, and mature oocytes) was assessed using linear and Poisson regression adjusted for chronological age, three surrogate variables (to account for cellular heterogeneity), race, smoking status, initial infertility diagnosis, and stimulation protocol.MAIN RESULTS AND ROLE OF CHANCE Compared to the median chronological age of our participants (34 years), the Horvath clock predicted, on an average, a younger epigenetic age (median: 24.2 years) while the GrimAge (median: 38.6 years) and Granulosa Cell (median: 39.0 years) clocks predicted, on an average, an older epigenetic age. Age acceleration based on the Horvath clock was associated with lower peak estradiol levels (-819.4 unit decrease in peak estradiol levels per standard deviation increase; 95% CI: -1265.7, -373.1) and fewer total (% change in total oocytes retrieved per standard deviation increase: -21.8%; 95% CI: -37.1%, -2.8%) and mature oocytes retrieved (% change in mature oocytes retrieved per standard deviation increase: -23.8%; 95% CI: -39.9%, -3.4%). The age acceleration based on the two other epigenetic clocks was not associated with markers of ovarian response.LIMITATIONS, REASONS FOR CAUTION Our sample size was small and we did not specifically isolate granulosa cells from follicular fluid samples so our samples could have included mixed cell types.WIDER IMPLICATIONS OF THE FINDINGS Our results highlight that certain epigenetic clocks may be predictive of ovarian stimulation outcomes when applied to follicular fluid; however, the inconsistent findings for specific clocks across studies indicate a need for further research to better understand the clinical utility of epigenetic clocks to improve IVF treatment.STUDY FUNDING/COMPETING INTEREST(S) The study was supported by grants ES009718, ES022955, ES000002, and ES026648 from the National Institute of Environmental Health Sciences (NIEHS) and a pilot grant from the NIEHS-funded HERCULES Center at Emory University (P30 ES019776). RBH was supported by the Emory University NIH Training Grant (T32-ES012870).TRIAL REGISTRATION NUMBER N/A.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Oxidative stress and inflammatory markers in ovarian follicular fluid of women with diminished ovarian reserve during in vitro fertilization
    Huang, Yan
    Cheng, Yi
    Zhang, Min
    Xia, Yan
    Chen, Xiaoyan
    Xian, Yexing
    Lin, Dewei
    Xie, Suyan
    Guo, Xinyu
    JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
  • [22] Follicular fluid lipid fingerprinting from women with PCOS and hyper response during IVF treatment
    Fernanda Bertuccez Cordeiro
    Thaís Regiani Cataldi
    Lívia do Vale Teixeira da Costa
    Camila Bruna de Lima
    Juliana Stevanato
    Daniel Suslik Zylbersztejn
    Christina Ramires Ferreira
    Marcos Nogueira Eberlin
    Agnaldo Pereira Cedenho
    Edson Guimarães Lo Turco
    Journal of Assisted Reproduction and Genetics, 2015, 32 : 45 - 54
  • [23] Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol
    Yao, Qi
    Liang, Yuanjiao
    Shao, Yong
    Bian, Wenwen
    Fu, Haiyan
    Xu, Juanjuan
    Sui, Liucai
    Yao, Bing
    Li, Meiling
    REPRODUCTIVE BIOMEDICINE ONLINE, 2018, 36 (01) : 20 - 25
  • [24] Variability of essential and non-essential trace elements in the follicular fluid of women undergoing in vitro fertilization (IVF)
    Butts, Celeste D.
    Bloom, Michael S.
    McGough, Alexandra
    Lenhart, Nikolaus
    Wong, Rebecca
    Mok-Lin, Evelyn
    Parsons, Patrick J.
    Galusha, Aubrey L.
    Yucel, Recai M.
    Feingold, Beth J.
    Browne, Richard W.
    Fujimoto, Victor Y.
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2021, 209
  • [25] Serum and follicular fluid organochlorine concentrations among women undergoing assisted reproduction technologies
    John D Meeker
    Stacey A Missmer
    Larisa Altshul
    Allison F Vitonis
    Louise Ryan
    Daniel W Cramer
    Russ Hauser
    Environmental Health, 8
  • [26] Serum Amyloid A: Expression Throughout Human Ovarian Folliculogenesis and Levels in Follicular Fluid of Women Undergoing Controlled Ovarian Stimulation
    Urieli-Shoval, Simcha
    Finci-Yeheskel, Zvesdana
    Eldar, Ido
    Linke, Reinhold P.
    Levin, Mark
    Prus, Diana
    Haimov-Kochman, Ronit
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (12): : 4970 - 4978
  • [27] The impact of follicular fluid phthalate metabolites on the ovarian reserve and ovarian function in Indian women undergoing intracytoplasmic sperm injection
    Parikh, Firuza Rajesh
    Uttamchandani, Shonali
    Sawkar, Sujatha
    Panpalia, Madhavi
    Naik, Nandkishor
    Sinkar, Prachi
    Kulkarni, Dhananjaya
    Parikh, Rajesh
    F&S SCIENCE, 2024, 5 (02): : 107 - 120
  • [28] Risks of conservative management in women with ovarian endometriomas undergoing IVF
    Somigliana, Edgardo
    Benaglia, Laura
    Paffoni, Alessio
    Busnelli, Andrea
    Vigano, Paola
    Vercellini, Paolo
    HUMAN REPRODUCTION UPDATE, 2015, 21 (04) : 486 - 499
  • [29] Prospective evaluation of early follicular ovarian stromal blood flow in infertile women undergoing IVF-ET treatment
    Jadaon, Jimmy E.
    Ben-Ami, Moshe
    Haddad, Sami
    Radin, Orit
    Bar-Ami, Shalom
    Younis, Johnny S.
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (05) : 356 - 359
  • [30] Cytokines in follicular fluid of women undergoing in vitro fertilization
    Jelusic, V
    Ljubic, A
    Veljkovic, M
    Majkic-Singh, N
    JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 2000, 19 (02): : 87 - 93